tirzepatide cardiovascular outcomes trial In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Lilly begins dosing in cardiovascular

Dose Escalation for Tolerability To reduce side effects, patients typically start at 0.25mg per week, then progress

OnlineOnce-weekly semaglutide 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial thelancet.com/journals/landi #obesity OnlineOnce-weekly semaglutide 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial thelancet.com/journals/landi #obesity Linked Comment by Priya Sumithran & Louise A Baur: Growing evidence for semaglutide efficacy in Asian adults with obesity thelancet.com/journals/landi #obesity

Bridge program NovoCare self-pay program: approximately $199 per month for starting doses (0.25/0.5 mg, first two fills through December 31, 2026), then approximately $349 per month for standard doses

Melanin is responsible for the appearance of dark spots and uneven skin tone

Chat staff were polite and helpful, but replies arrived through email about 24 hours later